D-1267-2020 Class III Terminated
FDA drug recall D-1267-2020 was initiated by Glaxosmithkline Consumer Healthcare Holdings on Apr 20, 2020 and is designated Class III. Reason for recall: Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card The recall status is terminated (terminated Oct 26, 2021). Affected quantity: 288 packages.
Recall details
- Product Type
- Drugs
- Report Date
- May 20, 2020
- Initiation Date
- Apr 20, 2020
- Termination Date
- Oct 26, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 288 packages
Product description
ChapStick Total Hydration Moisture + Tint + SPF15 Very Berry Net Wt. 0.08 OZ (2.2g) Marketed by: Pfizer, Madison, NJ 07940 USA NDC 0573-0872-08
Reason for recall
Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card
Distribution pattern
Nationwide
Code information
Lot #: 9346AA, 9347AA
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1267-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026